AU2287597A - Ophthalmological composition of the type which undergoes liquid-gel phase tr ansition - Google Patents

Ophthalmological composition of the type which undergoes liquid-gel phase tr ansition

Info

Publication number
AU2287597A
AU2287597A AU22875/97A AU2287597A AU2287597A AU 2287597 A AU2287597 A AU 2287597A AU 22875/97 A AU22875/97 A AU 22875/97A AU 2287597 A AU2287597 A AU 2287597A AU 2287597 A AU2287597 A AU 2287597A
Authority
AU
Australia
Prior art keywords
ansition
type
gel phase
ophthalmological composition
undergoes liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22875/97A
Inventor
Gilles Chastaing
Annouk Rozier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Merck Sharp and Dohme Chibret SAS
Original Assignee
Laboratories Merck Sharp and Dohme Chibret SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9603142A external-priority patent/FR2746014B1/en
Application filed by Laboratories Merck Sharp and Dohme Chibret SAS filed Critical Laboratories Merck Sharp and Dohme Chibret SAS
Publication of AU2287597A publication Critical patent/AU2287597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU22875/97A 1996-03-13 1997-03-12 Ophthalmological composition of the type which undergoes liquid-gel phase tr ansition Abandoned AU2287597A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1334396P 1996-03-13 1996-03-13
US60013343 1996-03-13
FR9603142A FR2746014B1 (en) 1996-03-13 1996-03-13 LIQUID-GEL PHASE TRANSITION TYPE OPHTHALMOLOGICAL COMPOSITION
FR9603142 1996-03-13
PCT/EP1997/001285 WO1997033562A1 (en) 1996-03-13 1997-03-12 Ophthalmological composition of the type which undergoes liquid-gel phase transition

Publications (1)

Publication Number Publication Date
AU2287597A true AU2287597A (en) 1997-10-01

Family

ID=26232584

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22875/97A Abandoned AU2287597A (en) 1996-03-13 1997-03-12 Ophthalmological composition of the type which undergoes liquid-gel phase tr ansition

Country Status (5)

Country Link
EP (1) EP0893990A1 (en)
JP (1) JP2000506182A (en)
AU (1) AU2287597A (en)
CA (1) CA2248881A1 (en)
WO (1) WO1997033562A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2685349C (en) * 1999-11-15 2013-09-17 Bio Syntech Canada Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
GR1004266B (en) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Pharmaceutical concoction for the diagnosis and therapy of erection problems
JP4725699B2 (en) * 2002-04-08 2011-07-13 ライオン株式会社 Ophthalmic composition and preservative for blending ophthalmic composition
JP2010031052A (en) * 2002-04-08 2010-02-12 Lion Corp Composition for ophthalmic use and antiseptic composition for ophthalmology preparation
CA3050535C (en) * 2014-12-15 2021-11-09 Richard Clark Kaufman Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of anti-inflammatory nutraceuticals
BR112019002967A2 (en) 2016-08-19 2019-05-14 Orasis Pharmaceuticals Ltd. ophthalmic pharmaceutical composition, methods of correcting presbyopia, reducing pupil size, inducing miosis, increasing depth of field, decreasing the magnitude of higher order aberrations, and improving near and far uncorrected visual acuity , implant and kit.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056420A1 (en) * 1981-01-15 1982-07-28 Schering Corporation Ophthalmic gel
SE9301877D0 (en) * 1993-06-02 1993-06-02 Kabi Pharmacia Ab IN SITU GEL FOR THERAPEUTIC USE

Also Published As

Publication number Publication date
JP2000506182A (en) 2000-05-23
WO1997033562A1 (en) 1997-09-18
EP0893990A1 (en) 1999-02-03
CA2248881A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU4851397A (en) Compositions for the preparation of leather
AU1875997A (en) Pharmaceutical composition for immunomodulation
AU5136998A (en) Medicinal composition
AU5590296A (en) Post-foamable foam composition
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU4557197A (en) Aerosol antiperspirant composition
AU4623997A (en) Shampoo composition
AU1592299A (en) Skin rash prevention composition
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU2287597A (en) Ophthalmological composition of the type which undergoes liquid-gel phase tr ansition
AU3263297A (en) New use of active ingredients which affect non-neuronal acetylcholine functions
AU6969498A (en) Skin cream composition
AU3460897A (en) Medicinal compositions
AU3191597A (en) Novel medicinal compositions of hydropyridines
AU7521796A (en) Microporous pathogen-killing composition
AU2621797A (en) Food foaming agent composition
AU1873299A (en) Deodorant composition
HUP9903751A3 (en) Intermediates for the preparation of 2-imidazoline-5-ones
AU4326197A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AUPN862596A0 (en) Pharmaceutical compositions
AU1504097A (en) Antiperspirant composition

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted